Price (delayed)
$0.1359
Market cap
$10M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.52
Enterprise value
$1.48M
Aravive, Inc. is a clinical-stage oncology company developing transformative therapeutics designed to halt the progression of life-threatening diseases. Aravive is based in Houston, Texas and received a Product Development Award
There are no recent dividends present for ARAV.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.